{"nct_id":"NCT06042049","title":"A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-05","start_date":"2023-07-27","start_date_type":"ACTUAL","primary_completion_date":"2024-09-10","primary_completion_date_type":"ACTUAL","completion_date":"2025-08-15","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}